We anticipate that fiscal 2020 revenue will range between 3.15 to $3.25 billion and diluted earnings per share to range between $2.95 and $3.15 per share.
Total company operating margin was 4.6% and diluted earnings per share were $0.43, reflecting two substantial impacts in the quarter.
We anticipate that fiscal 2020 revenue will range between 3.15 to $3.25 billion and diluted earnings per share to range between $2.95 and $3.15 per share.
Revenue for the second quarter of fiscal 2020 totaled $818.1 million, which included the full ramp-up of the Census contract in the US federal services segment.
We anticipate that fiscal 2020 revenue will range between 3.15 to $3.25 billion and diluted earnings per share to range between $2.95 and $3.15 per share.
First, we had a pandemic-related writedown of approximately $24 million or $0.28 per share related to the decline in estimates for future period outcomes-based payments on welfare-to-work programs in the United Kingdom and Australia.
This resulted in a pandemic related writedown of approximately $24 million or $0.28 per share related to a decline in estimates for future period outcomes-based payments on welfare-to-work programs in the United Kingdom and Australia.
Second, a change order for approximately $9 million or $0.11 per share was signed after quarter end in the US health and human services segment.
We were also selected to deliver the Federal Health and Human Services community-based testing centers or result center.
Cash from operations is now expected to range between 250 and $300 million and free cash flow between 200 to $250 million.
